ImmunityBio, Inc. (IBRX)
$9.91+1.64%Close
BUYRECOVERY · day 44
Key stats
Short interest · FINRA settlement 2026-09-15
52-week IV37.5%–194.0%
- Market cap
- $10.4B
- Beta
- 0.13
- P/E (TTM)
- -9.95
- IV-%ile
- 50
- IV ATM
- 97.8%
- Short % float
- 110.16%
- Days to cover
- 15.9
- SI change
- -0.2%
- 1W
- +6.79%
- 1M
- +22.95%
- vs SPY 1W
- +5.23%
- vs SPY 1M
- +21.19%
Industry peers
FMP comparable companies · ranked by market cap
- COGTSELLCogent Biosciences, Inc.$5.3BRECOVERYQ 12$31.02-0.20%
- DNLISELLDenali Therapeutics Inc.$3.2BCRISISQ 8$20.00-2.56%
- RCUSSELLArcus Biosciences, Inc.$3.1BCRISISQ 17$24.44-2.81%
- LQDASELLLiquidia Corporation$2.5BCRISISQ 13$28.64+5.02%
- BEAMSELLBeam Therapeutics Inc.$2.5BRECOVERYQ 13$24.50-0.69%
- ETNB89bio, Inc.$2.2B$14.84
- VRDNSELLViridian Therapeutics, Inc.$2.2BCRISISQ -3$19.40+0.33%
- RXRXBUYRecursion Pharmaceuticals, Inc.$2.2BCRISISQ 0$4.12-7.49%
- AGIOSELLAgios Pharmaceuticals, Inc.$1.9BRECOVERYQ 4$31.80+0.41%
- GLPGGalapagos N.V.$1.8B$27.98
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
